Global Malnutrition_ Market

Malnutrition_ Comprehensive Study by Type (Under Nutrition, Over Nutrition), Treatment (Intravenously (Par-enteral Nutrition), Gastrointestinal Tract (Enteral Nutrition)), Causes (A Low Intake Of Food, Mental Health Conditions, Social And Mobility Problems, Digestive Disorders, Stomach Conditions, Alcohol Use Disorder), Symptoms (Tiredness And Irritability, An Inability To Concentrate, Always Feeling Cold, Depression, Irritability And Anxiety, Other) Players and Region - Global Market Outlook to 2030

Malnutrition_ Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Malnutrition_
Malnutrition is a condition in which the body lacks the vitamins, minerals, and other nutrients it requires to maintain the health of its tissues and organs. Malnutrition affects people who are either undernourished or over nourished. In the United States, children suffer from malnutrition due to dietary imbalances rather than nutritional deficiencies. Under nutrition occurs when necessary nutrients are not consumed in sufficient quantities or are removed quicker than they can be replenished. Over nutrition occurs when people eat too much, consume the incorrect foods, do not exercise enough, or take too many vitamins or other dietary supplements. Over nutrition is more likely if you are more than 20% overweight or eat a high-fat, high-salt diet. In the United States, roughly 1% of children suffer from chronic malnutrition.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Malnutrition_ market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Johnson & Johnson (United States), Pfizer (United States), Novartis (Switzerland), AbbVie (United States), Merck (United States), Novo Nordisk (Denmark), Astrazeneca (United Kingdom), Bristol-Myers Squibb (United States), Viatris (United States) and Sun Pharmaceutical Industries (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Menarini (Italy) and Shionogi (Japan).

Segmentation Overview
AMA Research has segmented the market of Global Malnutrition_ market by Type (Under Nutrition and Over Nutrition) and Region.



On the basis of geography, the market of Malnutrition_ has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment, the sub-segment i.e. Intravenously (Par-enteral Nutrition) will boost the Malnutrition_ market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Causes, the sub-segment i.e. A Low Intake Of Food will boost the Malnutrition_ market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Symptoms, the sub-segment i.e. Tiredness And Irritability will boost the Malnutrition_ market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Surge In Demand For Nutrition In Emergence Of Developing Countries

Market Growth Drivers:
Increase In Number Of People Suffering From Malnutrition and Growing Geriatric Population

Challenges:
Intense Competition Among Player

Restraints:
High Cost Associated With Nutritional Products

Opportunities:
Increasing Investing In The Development Of Healthcare Infrastructure and Growing Demand For Nutritional Supplements Such As Single Tablets & Capsules


On 12 January 2022, These FDA Food Labeling web pages address the labeling requirements for foods under the Federal Food, Drug, and Cosmetic Act and its amendments. Food labeling is required for most prepared foods, such as breads, cereals, canned and frozen foods, snacks, desserts, drinks, etc. Nutrition labeling for raw produce (fruits and vegetables) and fish is voluntary. We refer to these products as "conventional" foods. For detailed information on dietary supplements, a special category of products that comes under the general umbrella of foods, but which has separate labeling requirements, see "Dietary Supplements."

Key Target Audience
Malnutrition, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Under Nutrition
  • Over Nutrition
By Treatment
  • Intravenously (Par-enteral Nutrition)
  • Gastrointestinal Tract (Enteral Nutrition)

By Causes
  • A Low Intake Of Food
  • Mental Health Conditions
  • Social And Mobility Problems
  • Digestive Disorders
  • Stomach Conditions
  • Alcohol Use Disorder

By Symptoms
  • Tiredness And Irritability
  • An Inability To Concentrate
  • Always Feeling Cold
  • Depression
  • Irritability And Anxiety
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase In Number Of People Suffering From Malnutrition
      • 3.2.2. Growing Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Intense Competition Among Player
    • 3.4. Market Trends
      • 3.4.1. Surge In Demand For Nutrition In Emergence Of Developing Countries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Malnutrition_, by Type, Treatment, Causes, Symptoms and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Malnutrition_ (Value)
      • 5.2.1. Global Malnutrition_ by: Type (Value)
        • 5.2.1.1. Under Nutrition
        • 5.2.1.2. Over Nutrition
      • 5.2.2. Global Malnutrition_ by: Treatment (Value)
        • 5.2.2.1. Intravenously (Par-enteral Nutrition)
        • 5.2.2.2. Gastrointestinal Tract (Enteral Nutrition)
      • 5.2.3. Global Malnutrition_ by: Causes (Value)
        • 5.2.3.1. A Low Intake Of Food
        • 5.2.3.2. Mental Health Conditions
        • 5.2.3.3. Social And Mobility Problems
        • 5.2.3.4. Digestive Disorders
        • 5.2.3.5. Stomach Conditions
        • 5.2.3.6. Alcohol Use Disorder
      • 5.2.4. Global Malnutrition_ by: Symptoms (Value)
        • 5.2.4.1. Tiredness And Irritability
        • 5.2.4.2. An Inability To Concentrate
        • 5.2.4.3. Always Feeling Cold
        • 5.2.4.4. Depression
        • 5.2.4.5. Irritability And Anxiety
        • 5.2.4.6. Other
      • 5.2.5. Global Malnutrition_ Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Malnutrition_ (Price)
      • 5.3.1. Global Malnutrition_ by: Type (Price)
  • 6. Malnutrition_: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Novartis (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. AbbVie (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Novo Nordisk (Denmark)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Astrazeneca (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bristol-Myers Squibb (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Viatris (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sun Pharmaceutical Industries (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Malnutrition_ Sale, by Type, Treatment, Causes, Symptoms and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Malnutrition_ (Value)
      • 7.2.1. Global Malnutrition_ by: Type (Value)
        • 7.2.1.1. Under Nutrition
        • 7.2.1.2. Over Nutrition
      • 7.2.2. Global Malnutrition_ by: Treatment (Value)
        • 7.2.2.1. Intravenously (Par-enteral Nutrition)
        • 7.2.2.2. Gastrointestinal Tract (Enteral Nutrition)
      • 7.2.3. Global Malnutrition_ by: Causes (Value)
        • 7.2.3.1. A Low Intake Of Food
        • 7.2.3.2. Mental Health Conditions
        • 7.2.3.3. Social And Mobility Problems
        • 7.2.3.4. Digestive Disorders
        • 7.2.3.5. Stomach Conditions
        • 7.2.3.6. Alcohol Use Disorder
      • 7.2.4. Global Malnutrition_ by: Symptoms (Value)
        • 7.2.4.1. Tiredness And Irritability
        • 7.2.4.2. An Inability To Concentrate
        • 7.2.4.3. Always Feeling Cold
        • 7.2.4.4. Depression
        • 7.2.4.5. Irritability And Anxiety
        • 7.2.4.6. Other
      • 7.2.5. Global Malnutrition_ Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Malnutrition_ (Price)
      • 7.3.1. Global Malnutrition_ by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Malnutrition_: by Type(USD Million)
  • Table 2. Malnutrition_ Under Nutrition , by Region USD Million (2018-2023)
  • Table 3. Malnutrition_ Over Nutrition , by Region USD Million (2018-2023)
  • Table 4. Malnutrition_: by Treatment(USD Million)
  • Table 5. Malnutrition_ Intravenously (Par-enteral Nutrition) , by Region USD Million (2018-2023)
  • Table 6. Malnutrition_ Gastrointestinal Tract (Enteral Nutrition) , by Region USD Million (2018-2023)
  • Table 7. Malnutrition_: by Causes(USD Million)
  • Table 8. Malnutrition_ A Low Intake Of Food , by Region USD Million (2018-2023)
  • Table 9. Malnutrition_ Mental Health Conditions , by Region USD Million (2018-2023)
  • Table 10. Malnutrition_ Social And Mobility Problems , by Region USD Million (2018-2023)
  • Table 11. Malnutrition_ Digestive Disorders , by Region USD Million (2018-2023)
  • Table 12. Malnutrition_ Stomach Conditions , by Region USD Million (2018-2023)
  • Table 13. Malnutrition_ Alcohol Use Disorder , by Region USD Million (2018-2023)
  • Table 14. Malnutrition_: by Symptoms(USD Million)
  • Table 15. Malnutrition_ Tiredness And Irritability , by Region USD Million (2018-2023)
  • Table 16. Malnutrition_ An Inability To Concentrate , by Region USD Million (2018-2023)
  • Table 17. Malnutrition_ Always Feeling Cold , by Region USD Million (2018-2023)
  • Table 18. Malnutrition_ Depression , by Region USD Million (2018-2023)
  • Table 19. Malnutrition_ Irritability And Anxiety , by Region USD Million (2018-2023)
  • Table 20. Malnutrition_ Other , by Region USD Million (2018-2023)
  • Table 21. South America Malnutrition_, by Country USD Million (2018-2023)
  • Table 22. South America Malnutrition_, by Type USD Million (2018-2023)
  • Table 23. South America Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 24. South America Malnutrition_, by Causes USD Million (2018-2023)
  • Table 25. South America Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 26. Brazil Malnutrition_, by Type USD Million (2018-2023)
  • Table 27. Brazil Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 28. Brazil Malnutrition_, by Causes USD Million (2018-2023)
  • Table 29. Brazil Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 30. Argentina Malnutrition_, by Type USD Million (2018-2023)
  • Table 31. Argentina Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 32. Argentina Malnutrition_, by Causes USD Million (2018-2023)
  • Table 33. Argentina Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 34. Rest of South America Malnutrition_, by Type USD Million (2018-2023)
  • Table 35. Rest of South America Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 36. Rest of South America Malnutrition_, by Causes USD Million (2018-2023)
  • Table 37. Rest of South America Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 38. Asia Pacific Malnutrition_, by Country USD Million (2018-2023)
  • Table 39. Asia Pacific Malnutrition_, by Type USD Million (2018-2023)
  • Table 40. Asia Pacific Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 41. Asia Pacific Malnutrition_, by Causes USD Million (2018-2023)
  • Table 42. Asia Pacific Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 43. China Malnutrition_, by Type USD Million (2018-2023)
  • Table 44. China Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 45. China Malnutrition_, by Causes USD Million (2018-2023)
  • Table 46. China Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 47. Japan Malnutrition_, by Type USD Million (2018-2023)
  • Table 48. Japan Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 49. Japan Malnutrition_, by Causes USD Million (2018-2023)
  • Table 50. Japan Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 51. India Malnutrition_, by Type USD Million (2018-2023)
  • Table 52. India Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 53. India Malnutrition_, by Causes USD Million (2018-2023)
  • Table 54. India Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 55. South Korea Malnutrition_, by Type USD Million (2018-2023)
  • Table 56. South Korea Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 57. South Korea Malnutrition_, by Causes USD Million (2018-2023)
  • Table 58. South Korea Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 59. Australia Malnutrition_, by Type USD Million (2018-2023)
  • Table 60. Australia Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 61. Australia Malnutrition_, by Causes USD Million (2018-2023)
  • Table 62. Australia Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Malnutrition_, by Type USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Malnutrition_, by Causes USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 67. Europe Malnutrition_, by Country USD Million (2018-2023)
  • Table 68. Europe Malnutrition_, by Type USD Million (2018-2023)
  • Table 69. Europe Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 70. Europe Malnutrition_, by Causes USD Million (2018-2023)
  • Table 71. Europe Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 72. Germany Malnutrition_, by Type USD Million (2018-2023)
  • Table 73. Germany Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 74. Germany Malnutrition_, by Causes USD Million (2018-2023)
  • Table 75. Germany Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 76. France Malnutrition_, by Type USD Million (2018-2023)
  • Table 77. France Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 78. France Malnutrition_, by Causes USD Million (2018-2023)
  • Table 79. France Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 80. Italy Malnutrition_, by Type USD Million (2018-2023)
  • Table 81. Italy Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 82. Italy Malnutrition_, by Causes USD Million (2018-2023)
  • Table 83. Italy Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 84. United Kingdom Malnutrition_, by Type USD Million (2018-2023)
  • Table 85. United Kingdom Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 86. United Kingdom Malnutrition_, by Causes USD Million (2018-2023)
  • Table 87. United Kingdom Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 88. Netherlands Malnutrition_, by Type USD Million (2018-2023)
  • Table 89. Netherlands Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 90. Netherlands Malnutrition_, by Causes USD Million (2018-2023)
  • Table 91. Netherlands Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 92. Rest of Europe Malnutrition_, by Type USD Million (2018-2023)
  • Table 93. Rest of Europe Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 94. Rest of Europe Malnutrition_, by Causes USD Million (2018-2023)
  • Table 95. Rest of Europe Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 96. MEA Malnutrition_, by Country USD Million (2018-2023)
  • Table 97. MEA Malnutrition_, by Type USD Million (2018-2023)
  • Table 98. MEA Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 99. MEA Malnutrition_, by Causes USD Million (2018-2023)
  • Table 100. MEA Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 101. Middle East Malnutrition_, by Type USD Million (2018-2023)
  • Table 102. Middle East Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 103. Middle East Malnutrition_, by Causes USD Million (2018-2023)
  • Table 104. Middle East Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 105. Africa Malnutrition_, by Type USD Million (2018-2023)
  • Table 106. Africa Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 107. Africa Malnutrition_, by Causes USD Million (2018-2023)
  • Table 108. Africa Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 109. North America Malnutrition_, by Country USD Million (2018-2023)
  • Table 110. North America Malnutrition_, by Type USD Million (2018-2023)
  • Table 111. North America Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 112. North America Malnutrition_, by Causes USD Million (2018-2023)
  • Table 113. North America Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 114. United States Malnutrition_, by Type USD Million (2018-2023)
  • Table 115. United States Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 116. United States Malnutrition_, by Causes USD Million (2018-2023)
  • Table 117. United States Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 118. Canada Malnutrition_, by Type USD Million (2018-2023)
  • Table 119. Canada Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 120. Canada Malnutrition_, by Causes USD Million (2018-2023)
  • Table 121. Canada Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 122. Mexico Malnutrition_, by Type USD Million (2018-2023)
  • Table 123. Mexico Malnutrition_, by Treatment USD Million (2018-2023)
  • Table 124. Mexico Malnutrition_, by Causes USD Million (2018-2023)
  • Table 125. Mexico Malnutrition_, by Symptoms USD Million (2018-2023)
  • Table 126. Malnutrition_: by Type(USD/Units)
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Malnutrition_: by Type(USD Million)
  • Table 138. Malnutrition_ Under Nutrition , by Region USD Million (2025-2030)
  • Table 139. Malnutrition_ Over Nutrition , by Region USD Million (2025-2030)
  • Table 140. Malnutrition_: by Treatment(USD Million)
  • Table 141. Malnutrition_ Intravenously (Par-enteral Nutrition) , by Region USD Million (2025-2030)
  • Table 142. Malnutrition_ Gastrointestinal Tract (Enteral Nutrition) , by Region USD Million (2025-2030)
  • Table 143. Malnutrition_: by Causes(USD Million)
  • Table 144. Malnutrition_ A Low Intake Of Food , by Region USD Million (2025-2030)
  • Table 145. Malnutrition_ Mental Health Conditions , by Region USD Million (2025-2030)
  • Table 146. Malnutrition_ Social And Mobility Problems , by Region USD Million (2025-2030)
  • Table 147. Malnutrition_ Digestive Disorders , by Region USD Million (2025-2030)
  • Table 148. Malnutrition_ Stomach Conditions , by Region USD Million (2025-2030)
  • Table 149. Malnutrition_ Alcohol Use Disorder , by Region USD Million (2025-2030)
  • Table 150. Malnutrition_: by Symptoms(USD Million)
  • Table 151. Malnutrition_ Tiredness And Irritability , by Region USD Million (2025-2030)
  • Table 152. Malnutrition_ An Inability To Concentrate , by Region USD Million (2025-2030)
  • Table 153. Malnutrition_ Always Feeling Cold , by Region USD Million (2025-2030)
  • Table 154. Malnutrition_ Depression , by Region USD Million (2025-2030)
  • Table 155. Malnutrition_ Irritability And Anxiety , by Region USD Million (2025-2030)
  • Table 156. Malnutrition_ Other , by Region USD Million (2025-2030)
  • Table 157. South America Malnutrition_, by Country USD Million (2025-2030)
  • Table 158. South America Malnutrition_, by Type USD Million (2025-2030)
  • Table 159. South America Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 160. South America Malnutrition_, by Causes USD Million (2025-2030)
  • Table 161. South America Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 162. Brazil Malnutrition_, by Type USD Million (2025-2030)
  • Table 163. Brazil Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 164. Brazil Malnutrition_, by Causes USD Million (2025-2030)
  • Table 165. Brazil Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 166. Argentina Malnutrition_, by Type USD Million (2025-2030)
  • Table 167. Argentina Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 168. Argentina Malnutrition_, by Causes USD Million (2025-2030)
  • Table 169. Argentina Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 170. Rest of South America Malnutrition_, by Type USD Million (2025-2030)
  • Table 171. Rest of South America Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 172. Rest of South America Malnutrition_, by Causes USD Million (2025-2030)
  • Table 173. Rest of South America Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 174. Asia Pacific Malnutrition_, by Country USD Million (2025-2030)
  • Table 175. Asia Pacific Malnutrition_, by Type USD Million (2025-2030)
  • Table 176. Asia Pacific Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 177. Asia Pacific Malnutrition_, by Causes USD Million (2025-2030)
  • Table 178. Asia Pacific Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 179. China Malnutrition_, by Type USD Million (2025-2030)
  • Table 180. China Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 181. China Malnutrition_, by Causes USD Million (2025-2030)
  • Table 182. China Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 183. Japan Malnutrition_, by Type USD Million (2025-2030)
  • Table 184. Japan Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 185. Japan Malnutrition_, by Causes USD Million (2025-2030)
  • Table 186. Japan Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 187. India Malnutrition_, by Type USD Million (2025-2030)
  • Table 188. India Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 189. India Malnutrition_, by Causes USD Million (2025-2030)
  • Table 190. India Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 191. South Korea Malnutrition_, by Type USD Million (2025-2030)
  • Table 192. South Korea Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 193. South Korea Malnutrition_, by Causes USD Million (2025-2030)
  • Table 194. South Korea Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 195. Australia Malnutrition_, by Type USD Million (2025-2030)
  • Table 196. Australia Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 197. Australia Malnutrition_, by Causes USD Million (2025-2030)
  • Table 198. Australia Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 199. Rest of Asia-Pacific Malnutrition_, by Type USD Million (2025-2030)
  • Table 200. Rest of Asia-Pacific Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 201. Rest of Asia-Pacific Malnutrition_, by Causes USD Million (2025-2030)
  • Table 202. Rest of Asia-Pacific Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 203. Europe Malnutrition_, by Country USD Million (2025-2030)
  • Table 204. Europe Malnutrition_, by Type USD Million (2025-2030)
  • Table 205. Europe Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 206. Europe Malnutrition_, by Causes USD Million (2025-2030)
  • Table 207. Europe Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 208. Germany Malnutrition_, by Type USD Million (2025-2030)
  • Table 209. Germany Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 210. Germany Malnutrition_, by Causes USD Million (2025-2030)
  • Table 211. Germany Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 212. France Malnutrition_, by Type USD Million (2025-2030)
  • Table 213. France Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 214. France Malnutrition_, by Causes USD Million (2025-2030)
  • Table 215. France Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 216. Italy Malnutrition_, by Type USD Million (2025-2030)
  • Table 217. Italy Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 218. Italy Malnutrition_, by Causes USD Million (2025-2030)
  • Table 219. Italy Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 220. United Kingdom Malnutrition_, by Type USD Million (2025-2030)
  • Table 221. United Kingdom Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 222. United Kingdom Malnutrition_, by Causes USD Million (2025-2030)
  • Table 223. United Kingdom Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 224. Netherlands Malnutrition_, by Type USD Million (2025-2030)
  • Table 225. Netherlands Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 226. Netherlands Malnutrition_, by Causes USD Million (2025-2030)
  • Table 227. Netherlands Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 228. Rest of Europe Malnutrition_, by Type USD Million (2025-2030)
  • Table 229. Rest of Europe Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 230. Rest of Europe Malnutrition_, by Causes USD Million (2025-2030)
  • Table 231. Rest of Europe Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 232. MEA Malnutrition_, by Country USD Million (2025-2030)
  • Table 233. MEA Malnutrition_, by Type USD Million (2025-2030)
  • Table 234. MEA Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 235. MEA Malnutrition_, by Causes USD Million (2025-2030)
  • Table 236. MEA Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 237. Middle East Malnutrition_, by Type USD Million (2025-2030)
  • Table 238. Middle East Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 239. Middle East Malnutrition_, by Causes USD Million (2025-2030)
  • Table 240. Middle East Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 241. Africa Malnutrition_, by Type USD Million (2025-2030)
  • Table 242. Africa Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 243. Africa Malnutrition_, by Causes USD Million (2025-2030)
  • Table 244. Africa Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 245. North America Malnutrition_, by Country USD Million (2025-2030)
  • Table 246. North America Malnutrition_, by Type USD Million (2025-2030)
  • Table 247. North America Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 248. North America Malnutrition_, by Causes USD Million (2025-2030)
  • Table 249. North America Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 250. United States Malnutrition_, by Type USD Million (2025-2030)
  • Table 251. United States Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 252. United States Malnutrition_, by Causes USD Million (2025-2030)
  • Table 253. United States Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 254. Canada Malnutrition_, by Type USD Million (2025-2030)
  • Table 255. Canada Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 256. Canada Malnutrition_, by Causes USD Million (2025-2030)
  • Table 257. Canada Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 258. Mexico Malnutrition_, by Type USD Million (2025-2030)
  • Table 259. Mexico Malnutrition_, by Treatment USD Million (2025-2030)
  • Table 260. Mexico Malnutrition_, by Causes USD Million (2025-2030)
  • Table 261. Mexico Malnutrition_, by Symptoms USD Million (2025-2030)
  • Table 262. Malnutrition_: by Type(USD/Units)
  • Table 263. Research Programs/Design for This Report
  • Table 264. Key Data Information from Secondary Sources
  • Table 265. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Malnutrition_: by Type USD Million (2018-2023)
  • Figure 5. Global Malnutrition_: by Treatment USD Million (2018-2023)
  • Figure 6. Global Malnutrition_: by Causes USD Million (2018-2023)
  • Figure 7. Global Malnutrition_: by Symptoms USD Million (2018-2023)
  • Figure 8. South America Malnutrition_ Share (%), by Country
  • Figure 9. Asia Pacific Malnutrition_ Share (%), by Country
  • Figure 10. Europe Malnutrition_ Share (%), by Country
  • Figure 11. MEA Malnutrition_ Share (%), by Country
  • Figure 12. North America Malnutrition_ Share (%), by Country
  • Figure 13. Global Malnutrition_: by Type USD/Units (2018-2023)
  • Figure 14. Global Malnutrition_ share by Players 2023 (%)
  • Figure 15. Global Malnutrition_ share by Players (Top 3) 2023(%)
  • Figure 16. Global Malnutrition_ share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 19. Johnson & Johnson (United States) Revenue: by Geography 2023
  • Figure 20. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 21. Pfizer (United States) Revenue: by Geography 2023
  • Figure 22. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Novartis (Switzerland) Revenue: by Geography 2023
  • Figure 24. AbbVie (United States) Revenue, Net Income and Gross profit
  • Figure 25. AbbVie (United States) Revenue: by Geography 2023
  • Figure 26. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 27. Merck (United States) Revenue: by Geography 2023
  • Figure 28. Novo Nordisk (Denmark) Revenue, Net Income and Gross profit
  • Figure 29. Novo Nordisk (Denmark) Revenue: by Geography 2023
  • Figure 30. Astrazeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. Astrazeneca (United Kingdom) Revenue: by Geography 2023
  • Figure 32. Bristol-Myers Squibb (United States) Revenue, Net Income and Gross profit
  • Figure 33. Bristol-Myers Squibb (United States) Revenue: by Geography 2023
  • Figure 34. Viatris (United States) Revenue, Net Income and Gross profit
  • Figure 35. Viatris (United States) Revenue: by Geography 2023
  • Figure 36. Sun Pharmaceutical Industries (India) Revenue, Net Income and Gross profit
  • Figure 37. Sun Pharmaceutical Industries (India) Revenue: by Geography 2023
  • Figure 38. Global Malnutrition_: by Type USD Million (2025-2030)
  • Figure 39. Global Malnutrition_: by Treatment USD Million (2025-2030)
  • Figure 40. Global Malnutrition_: by Causes USD Million (2025-2030)
  • Figure 41. Global Malnutrition_: by Symptoms USD Million (2025-2030)
  • Figure 42. South America Malnutrition_ Share (%), by Country
  • Figure 43. Asia Pacific Malnutrition_ Share (%), by Country
  • Figure 44. Europe Malnutrition_ Share (%), by Country
  • Figure 45. MEA Malnutrition_ Share (%), by Country
  • Figure 46. North America Malnutrition_ Share (%), by Country
  • Figure 47. Global Malnutrition_: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Johnson & Johnson (United States)
  • Pfizer (United States)
  • Novartis (Switzerland)
  • AbbVie (United States)
  • Merck (United States)
  • Novo Nordisk (Denmark)
  • Astrazeneca (United Kingdom)
  • Bristol-Myers Squibb (United States)
  • Viatris (United States)
  • Sun Pharmaceutical Industries (India)
Additional players considered in the study are as follows:
Menarini (Italy) , Shionogi (Japan)
Select User Access Type

Key Highlights of Report


Apr 2024 245 Pages 72 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Malnutrition_ Market Quantitative research analysis
Global Malnutrition_ Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Johnson & Johnson (United States), Pfizer (United States), Novartis (Switzerland), AbbVie (United States), Merck (United States), Novo Nordisk (Denmark), Astrazeneca (United Kingdom), Bristol-Myers Squibb (United States), Viatris (United States) and Sun Pharmaceutical Industries (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Surge In Demand For Nutrition In Emergence Of Developing Countries" is seen as one of major influencing trends for Malnutrition_ Market during projected period 2023-2030.
The Malnutrition_ market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Malnutrition_ Market Report?

Have a Query? Click Here

Other Related Reports

Immune Cell Therapy Comprehensive Study by Application (Cancer, Autoimmune Disease, Chronic Inflammation), Forms (Nonspecific Immunotherapies, Cancer Vaccines), End User (Hospitals, Cancer Research C...
$ 3400
Oxycodone Drug Comprehensive Study by Distribution Channel (Online {Company Website, E-Commerce Website}, Offline {Pharma Stores, Local Medical Stores}), End Use (Hospitals, Clinics, Diagnostic Cente...
$ 3800
Spiramycin Drug Comprehensive Study by Type (Oral route {Capsule, Tablets}, Rectal route {Suppository}, Injection route), Disease (Toxoplasmosis, Cryptosporidiosis), Distribution Channel (Hospital ph...
$ 3800
Argininemia Drugs- Comprehensive Study by Medications (Protein Intake Limited, Sodium Benzoate, Sodium Phenylbutyrate, Carglumic Acid, Others), Diagnosis (Plasma Ammonia Concentration, Urinary Orotic...
$ 3500
Perineural Therapy Comprehensive Study by Type (Internal Neurostimulation Devices {Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrical Stimulation, Spinal Cord Stimulation, Deep Bra...
$ 3800
Triptorelin Drug- Comprehensive Study by Application (Advanced prostate cancer, Endometriosis, Uterine fibroids, Precocious puberty), Doses Forms (3.75 mg Vial, 11.25 mg Vial, 22.5 mg Vial) Players a...
$ 3400